{"id":1718,"date":"2021-01-27T10:32:40","date_gmt":"2021-01-27T09:32:40","guid":{"rendered":"https:\/\/b2rlaw.com\/?p=1718"},"modified":"2021-01-27T10:32:40","modified_gmt":"2021-01-27T09:32:40","slug":"b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania","status":"publish","type":"post","link":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/","title":{"rendered":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania"},"content":{"rendered":"

Kancelaria B2RLaw doradza\u0142a Ambulero, Inc, sp\u00f3\u0142ce biotechnologicznej rozwijaj\u0105cej terapie kom\u00f3rkowe i genowe dla pacjent\u00f3w cierpi\u0105cych na choroby naczyniowe, w zwi\u0105zku z pozyskaniem finansowania od Orphinic Scientific, kt\u00f3re mo\u017ce wynie\u015b\u0107 do 5,5 mln USD.<\/p>\n

\"\"<\/p>\n

W ramach inwestycji, z pomoc\u0105 B2RLaw, Ambulero i Orphinic utworzy\u0142y polsk\u0105 sp\u00f3\u0142k\u0119 zale\u017cn\u0105 (Ambulero Sp. z o.o.), kt\u00f3ra b\u0119dzie prowadzi\u0107 w Europie testy kliniczne nowej terapii genowej powa\u017cnej choroby naczyniowej. Choroba ta\u00a0 rzadko wyst\u0119puje w USA, natomiast w niekt\u00f3rych cz\u0119\u015bciach Europy \u015arodkowej i Wschodniej jest bardzo powszechna.<\/p>\n

Ambulero jest firm\u0105 biotechnologiczn\u0105 zajmuj\u0105c\u0105 si\u0119 rozwojem platformy terapii kom\u00f3rkowych i genowych w leczeniu powa\u017cnych chor\u00f3b naczyniowych. Jest to firma typu spin-out<\/em> Uniwersytetu Miami z 2019 roku, kt\u00f3rej wsp\u00f3\u0142za\u0142o\u017cycielami s\u0105 Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez i Jun Zhao-Liu. Firma posiada wy\u0142\u0105czn\u0105 licencj\u0119 od Uniwersytetu Miami na rozw\u00f3j i komercjalizacj\u0119 bada\u0144 prowadzonych w laboratoriach doktor\u00f3w Omaidy C. Velazquez i Jun Zhao-Liu.<\/p>\n

Orphinic Scientific, z biurami w Palo Alto w Kalifornii i w Warszawie, jest innowacyjn\u0105 firm\u0105 zajmuj\u0105c\u0105 si\u0119 opracowywaniem i inwestowaniem w leki, koncentruj\u0105c\u0105 si\u0119 na \u015brednich rynkach oraz lekach sierocych w p\u00f3\u017anym stadium bada\u0144 przedklinicznych i fazie 1 lub 2.<\/p>\n

Zespo\u0142em prawnik\u00f3w B2RLaw doradzaj\u0105cych przy transakcji kierowa\u0142 Szymon Syp (Partner), a w jego sk\u0142ad wchodzili Iga Wojtczak \u2013 Opala (Starszy Prawnik) oraz Jakub Niemiec (M\u0142odszy Prawnik).<\/p>\n

„Pragniemy pogratulowa\u0107 Ambulero i Orphinic Scientific tej transakcji. Wa\u017cna praca jak\u0105 wykonuje Ambulero oznacza, \u017ce ludzie cierpi\u0105cy na powa\u017cne choroby naczyniowe (kt\u00f3re w najlepszym przypadku powoduj\u0105 powa\u017cny dyskomfort, a w najgorszym mog\u0105 doprowadzi\u0107 do \u015bmierci) mog\u0105 \u017cy\u0107 w spokoju wiedz\u0105c, \u017ce na horyzoncie pojawia si\u0119 innowacyjne leczenie. \u017byczymy Ambulero powodzenia w przysz\u0142ych testach klinicznych” \u2013 komentuje Szymon Syp.<\/p>\n","protected":false},"excerpt":{"rendered":"

Kancelaria B2RLaw doradza\u0142a Ambulero, Inc, sp\u00f3\u0142ce biotechnologicznej rozwijaj\u0105cej terapie kom\u00f3rkowe i genowe dla pacjent\u00f3w cierpi\u0105cych na choroby naczyniowe, w zwi\u0105zku […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"class_list":["post-1718","post","type-post","status-publish","format-standard","hentry","category-aktualnosci"],"acf":[],"yoast_head":"\nB2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW\" \/>\n<meta property=\"og:description\" content=\"Kancelaria B2RLaw doradza\u0142a Ambulero, Inc, sp\u00f3\u0142ce biotechnologicznej rozwijaj\u0105cej terapie kom\u00f3rkowe i genowe dla pacjent\u00f3w cierpi\u0105cych na choroby naczyniowe, w zwi\u0105zku […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/\" \/>\n<meta property=\"og:site_name\" content=\"B2RLAW\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-27T09:32:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg\" \/>\n<meta name=\"author\" content=\"b2r\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"b2r\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/\"},\"author\":{\"name\":\"b2r\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/#\\\/schema\\\/person\\\/2ef801a8f1a40a43573f705c6cf8ea73\"},\"headline\":\"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania\",\"datePublished\":\"2021-01-27T09:32:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/\"},\"wordCount\":320,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/b2rlaw.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/91413670_xl.jpg\",\"articleSection\":[\"Aktualno\u015bci\"],\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/\",\"url\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/\",\"name\":\"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/b2rlaw.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/91413670_xl.jpg\",\"datePublished\":\"2021-01-27T09:32:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/#\\\/schema\\\/person\\\/2ef801a8f1a40a43573f705c6cf8ea73\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#primaryimage\",\"url\":\"https:\\\/\\\/b2rlaw.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/91413670_xl.jpg\",\"contentUrl\":\"https:\\\/\\\/b2rlaw.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/91413670_xl.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/sample-page\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/#website\",\"url\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/\",\"name\":\"B2RLAW\",\"description\":\"We have extensive experience acting in specialized and complex deals and disputes.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/b2rlaw.com\\\/pl\\\/#\\\/schema\\\/person\\\/2ef801a8f1a40a43573f705c6cf8ea73\",\"name\":\"b2r\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g\",\"caption\":\"b2r\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/","og_locale":"pl_PL","og_type":"article","og_title":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW","og_description":"Kancelaria B2RLaw doradza\u0142a Ambulero, Inc, sp\u00f3\u0142ce biotechnologicznej rozwijaj\u0105cej terapie kom\u00f3rkowe i genowe dla pacjent\u00f3w cierpi\u0105cych na choroby naczyniowe, w zwi\u0105zku […]","og_url":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/","og_site_name":"B2RLAW","article_published_time":"2021-01-27T09:32:40+00:00","og_image":[{"url":"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg","type":"","width":"","height":""}],"author":"b2r","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"b2r","Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#article","isPartOf":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/"},"author":{"name":"b2r","@id":"https:\/\/b2rlaw.com\/pl\/#\/schema\/person\/2ef801a8f1a40a43573f705c6cf8ea73"},"headline":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania","datePublished":"2021-01-27T09:32:40+00:00","mainEntityOfPage":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/"},"wordCount":320,"commentCount":0,"image":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#primaryimage"},"thumbnailUrl":"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg","articleSection":["Aktualno\u015bci"],"inLanguage":"pl-PL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/","url":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/","name":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania - B2RLAW","isPartOf":{"@id":"https:\/\/b2rlaw.com\/pl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#primaryimage"},"image":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#primaryimage"},"thumbnailUrl":"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg","datePublished":"2021-01-27T09:32:40+00:00","author":{"@id":"https:\/\/b2rlaw.com\/pl\/#\/schema\/person\/2ef801a8f1a40a43573f705c6cf8ea73"},"breadcrumb":{"@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#primaryimage","url":"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg","contentUrl":"https:\/\/b2rlaw.com\/wp-content\/uploads\/2021\/01\/91413670_xl.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/b2rlaw.com\/pl\/b2rlaw-doradzala-spolce-biotechnologicznej-ambulero-w-pozyskaniu-finansowania\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/b2rlaw.com\/pl\/sample-page\/"},{"@type":"ListItem","position":2,"name":"B2RLaw doradza\u0142a sp\u00f3\u0142ce biotechnologicznej Ambulero w pozyskaniu finansowania"}]},{"@type":"WebSite","@id":"https:\/\/b2rlaw.com\/pl\/#website","url":"https:\/\/b2rlaw.com\/pl\/","name":"B2RLAW","description":"We have extensive experience acting in specialized and complex deals and disputes.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/b2rlaw.com\/pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Person","@id":"https:\/\/b2rlaw.com\/pl\/#\/schema\/person\/2ef801a8f1a40a43573f705c6cf8ea73","name":"b2r","image":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/secure.gravatar.com\/avatar\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d33c9cf07b732ae07942e10a8ad013152eb282475d95c7db934c478bb893f6dd?s=96&d=mm&r=g","caption":"b2r"}}]}},"_links":{"self":[{"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/posts\/1718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/comments?post=1718"}],"version-history":[{"count":1,"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/posts\/1718\/revisions"}],"predecessor-version":[{"id":1719,"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/posts\/1718\/revisions\/1719"}],"wp:attachment":[{"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/media?parent=1718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/b2rlaw.com\/pl\/wp-json\/wp\/v2\/categories?post=1718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}